BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$414M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$371M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$342M |
| 4 |
Microsoft
MSFT
|
+$339M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Salesforce
CRM
|
+$688M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$338M |
| 4 |
Eli Lilly
LLY
|
+$239M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.68% |
| 2 | Consumer Discretionary | 5.92% |
| 3 | Healthcare | 5.84% |
| 4 | Financials | 5.12% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
AngloGold Ashanti
AU
$48.1B
| $1.96M | ﹤0.01% |
66,523
-105,924
| -61% | -$2.62M |
|
1402
PUT
iShares Biotechnology ETF
IBB
$9.77B
| $1.95M | ﹤0.01% |
143
-82
| -36% | -$10.5K |
|
1403
Targa Resources
TRGP
$57.2B
| $1.95M | ﹤0.01% |
97,251
-70,156
| -42% | -$1.05M |
|
1404
Aramark
ARMK
$16.1B
| $1.95M | ﹤0.01% |
119,473
-176,669
| -60% | -$3.1M |
|
1405
CALL
Best Buy
BBY
$18B
| $1.95M | ﹤0.01% |
223
-72
| -24% | -$5.46K |
|
1406
Crane NXT
CXT
$2.96B
| $1.94M | ﹤0.01% |
94,002
+83,142
| +766% | +$1.55M |
|
1407
TFS Financial
TFSL
$4.93B
| $1.93M | ﹤0.01% |
134,962
+126,824
| +1,558% | +$1.83M |
|
|
AAWW
1408
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $1.93M | ﹤0.01% |
44,811
-13,165
| -23% | -$462K |
|
1409
Tradeweb Markets
TW
$22.3B
| $1.91M | ﹤0.01% |
32,794
+30,664
| +1,440% | +$1.77M |
|
1410
CALL
Live Nation Entertainment
LYV
$43.3B
| $1.91M | ﹤0.01% |
+430
| New | +$18.8K |
|
|
CLVS
1411
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.9M | ﹤0.01% |
281,982
-9,011
| -3% | -$68.2K |
|
1412
Acadia Pharmaceuticals
ACAD
$4.89B
| $1.89M | ﹤0.01% |
38,999
-35,037
| -47% | -$1.68M |
|
1413
PUT
Paychex
PAYX
$44.6B
| $1.88M | ﹤0.01% |
248
-236
| -49% | -$16.4K |
|
1414
iShares MSCI Japan ETF
EWJ
$23.2B
| $1.88M | ﹤0.01% |
34,179
-3,158
| -8% | -$168K |
|
1415
Hanover Insurance
THG
$7.77B
| $1.87M | ﹤0.01% |
18,437
-29,520
| -62% | -$2.89M |
|
1416
Cinemark Holdings
CNK
$4.37B
| $1.86M | ﹤0.01% |
161,379
-235,969
| -59% | -$3.2M |
|
1417
CALL
Jack in the Box
JACK
$358M
| $1.85M | ﹤0.01% |
+250
| New | +$15.4K |
|
|
1418
PUT
Jack in the Box
JACK
$358M
| $1.85M | ﹤0.01% |
+250
| New | +$15.4K |
|
|
ALXN
1419
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.85M | ﹤0.01% |
165
-1,274
| -89% | -$135K |
|
|
FISV
1420
CALL
Fiserv Inc
FISV
$29.5B
| $1.85M | ﹤0.01% |
189
| – | – |
|
1421
FTI Consulting
FCN
$4.24B
| $1.84M | ﹤0.01% |
16,076
-32,448
| -67% | -$3.93M |
|
1422
Viavi Solutions
VIAV
$10.6B
| $1.84M | ﹤0.01% |
144,434
+45,852
| +47% | +$550K |
|
1423
Integra LifeSciences
IART
$1.42B
| $1.84M | ﹤0.01% |
39,146
-35,062
| -47% | -$1.72M |
|
|
EPAY
1424
DELISTED
Bottomline Technologies Inc
EPAY
| $1.84M | ﹤0.01% |
36,213
-29,235
| -45% | -$1.31M |
|
1425
Antero Midstream
AM
$10.5B
| $1.84M | ﹤0.01% |
360,447
+163,025
| +83% | +$722K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2020 Portfolio in Review
As of Q2 2020, BNP Paribas Financial Markets held 4,480 positions worth $56.7B, up 16% from $48.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.34B in Q2 2020, closing 174 positions and reducing 2,678 holdings. Its most notable exit was Allergan plc, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $35.2M.
- BNP Paribas Financial Markets's largest Q2 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 962,483 shares worth $35.2M.
- BNP Paribas Financial Markets added most to Apple in Q2 2020, an estimated $414M increase.
- BNP Paribas Financial Markets's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2020, selling an estimated $225M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $56.7B portfolio in Q2 2020.
- BNP Paribas Financial Markets opened 164 new positions and closed 174 in Q2 2020.
- BNP Paribas Financial Markets's portfolio value rose 16% quarter-over-quarter to $56.7B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.